Product containing precisely loteprednol etabonate 5 milligram/1 milliliter and tobramycin 3 milligram/1 milliliter conventional release eye suspension (clinical drug)
loteprednol-tobramycin ophthalmic 0.5%-0.3% ophthalmic suspension